All posts in
Dutch and German Biotechs enter the Clinic with their First Lanthipeptide
UPDATE: More Promising Results from Mologen’s New HIV Therapy
Which European Country is Winning the Race in Clinical Development?
Germany gains Strength in Allergy Immunotherapeutics
German Biotech gets Seed Funding to Repurpose Cancer Drugs for the Flu
Could GM Insects impact the international trade of Organic Food?
Meet these 3 Exciting German Startups Pitching in Aachen Today!
Young German Immune Therapy Biotech expands its Series A Funding
Researchers are One Step Closer to Understanding Artificial Silk
Epigenetics Drug Improves Survival in the Second Deadliest Cancer
French Biotech partners with Merck to Fight Tumor Resistance
Giant Chickens and Bioluminiscent Squids Invade Berlin
Labiotech UG, All Rights Reserved -
Send this to friend